Literature DB >> 8110545

Propofol infusion and the suppression of consciousness: dose requirements to induce loss of consciousness and to suppress response to noxious and non-noxious stimuli.

J M Dunnet1, C Prys-Roberts, D E Holland, B L Browne.   

Abstract

We have defined the infusion dose requirements of propofol to suppress consciousness and response to a variety of graded non-noxious and noxious stimuli in 52 unpremedicated patients aged 16-40 yr and 32 patients aged 41-65 yr. They were allocated to receive one of five loading dose-infusion schemes designed to establish stable conditions covering the range from wakefulness, through sedation, to loss of consciousness and anaesthesia. At 10 and 20 min after the loading dose, each patient's response to a graded series of stimuli was recorded. Probit analysis was used to derive mean values (95% confidence interval) for the ED50 and ED95 (as final infusion rate) for loss of response to verbal command at 4.9 (4.7-5.1) mg kg-1 h-1 and 7.9 (7.3-8.8) mg kg-1 h-1, respectively, in the young group and 4.2 (4.0-4.4) mg kg-1 h-1 and 5.8 (5.4-6.4) mg kg-1 h-1, respectively, in the older group. In both groups the dose-response curves for suppression of proprioception, finger counting and perception of light touch in conscious patients were shifted to the left of the curves for loss of consciousness and eyelash reflex. Dose-response curves for noxious stimuli were shifted to the right of those for loss of consciousness.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8110545     DOI: 10.1093/bja/72.1.29

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

1.  Brain mechanisms of propofol-induced loss of consciousness in humans: a positron emission tomographic study.

Authors:  P Fiset; T Paus; T Daloze; G Plourde; P Meuret; V Bonhomme; N Hajj-Ali; S B Backman; A C Evans
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

2.  Consumption and distribution of propofol in anaesthesia and intensive care use in Finland.

Authors:  Hannu Kokki; Ulla Närhi
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

3.  Humanely Ending the Life of Animals: Research Priorities to Identify Alternatives to Carbon Dioxide.

Authors:  Aline R Steiner; Shannon Axiak Flammer; Ngaio J Beausoleil; Charlotte Berg; Regula Bettschart-Wolfensberger; Rebeca García Pinillos; Huw D W Golledge; Michael Marahrens; Robert Meyer; Tobias Schnitzer; Michael J Toscano; Patricia V Turner; Daniel M Weary; Thomas C Gent
Journal:  Animals (Basel)       Date:  2019-11-02       Impact factor: 2.752

4.  Neuroplasticity induced by general anaesthesia: study protocol for a randomised cross-over clinical trial exploring the effects of sevoflurane and propofol on the brain - A 3-T magnetic resonance imaging study of healthy volunteers.

Authors:  Signe Sloth Madsen; Kirsten Møller; Karsten Skovgaard Olsen; Mark Bitsch Vestergaard; Ulrich Lindberg; Henrik Bo Wiberg Larsson; Johan Mårtensson; Mads U Werner; Sofia Alexandra Gaspar Santos; Mohammad Sohail Asghar
Journal:  Trials       Date:  2020-09-22       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.